| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 319.87B | 304.77B | 287.27B | 284.94B | 263.11B |
| Gross Profit | 100.11B | 93.55B | 85.71B | 81.35B | 80.41B |
| EBITDA | 48.75B | 42.91B | 45.45B | 40.84B | 39.40B |
| Net Income | 28.01B | 19.28B | 21.83B | 20.29B | 18.30B |
Balance Sheet | |||||
| Total Assets | 484.17B | 417.78B | 441.16B | 378.46B | 370.84B |
| Cash, Cash Equivalents and Short-Term Investments | 124.75B | 103.53B | 121.64B | 99.62B | 109.22B |
| Total Debt | 27.36B | 30.68B | 48.53B | 43.23B | 58.62B |
| Total Liabilities | 133.52B | 124.21B | 137.44B | 120.77B | 138.70B |
| Stockholders Equity | 347.19B | 290.67B | 301.16B | 255.36B | 229.78B |
Cash Flow | |||||
| Free Cash Flow | 19.56B | 28.07B | 18.27B | 8.65B | 15.51B |
| Operating Cash Flow | 35.00B | 43.71B | 40.22B | 23.62B | 27.92B |
| Investing Cash Flow | -7.93B | -15.60B | -21.12B | -15.65B | -10.47B |
| Financing Cash Flow | -13.58B | -44.88B | -6.28B | -22.95B | -19.31B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥549.18B | 22.24 | 6.52% | 1.82% | 4.95% | 52.94% | |
73 Outperform | ¥321.38B | 10.92 | 5.47% | 3.41% | 0.55% | 25.37% | |
67 Neutral | ¥286.05B | 12.02 | 1.47% | 4.29% | -5.02% | ― | |
64 Neutral | ¥453.12B | 10.07 | 8.14% | 2.61% | -0.45% | 50.53% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
58 Neutral | ¥1.05T | -26.78 | -2.50% | 3.49% | -4.57% | -190.44% | |
55 Neutral | ¥331.26B | 34.75 | 9.34% | 4.27% | -1.18% | -78.57% |